# Texas Biolabs Private Limited – FDA Inspection, Mar 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/texas-biolabs-private-limited/c8ee3a74-f491-4f7c-b0bd-16a9914986ce
Source feed: FDA_Inspections

> FDA inspection 1201546 of Texas Biolabs Private Limited, March 15, 2023. Classification: No Action Indicated (NAI). 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1201546
- Company Name: Texas Biolabs Private Limited
- Inspection Date: 2023-03-15
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- FDA Inspection 1206106 - 2023-04-21
- FDA Inspection 1037081 - 2017-12-19
- FDA Inspection 993199 - 2016-10-21

## Related Officers

- [Company Rep](https://www.keypedia.com/people/craig-a-garmendia/6a17e361-7085-4d55-92b2-37fcaf2f55de)

Company: https://www.keypedia.com/companies/texas-biolabs-private-limited/130d3744-dbbb-4451-a308-446680fae92f

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c